Introduction
It iscommonknowledge thatsecondary auralcholesteatoma is an epidermoid cyst comprising a matrix and a perimatrix or laminapropria.1,2,3 The matrix iscomposedofkeratinized squamous epithelium and includes several layers: basal or germinative(withMerkel's cells),malpighianor spinal(with Langerhans' cells),granular withkeratohyalingranules,and hyperkeratotic with desquamation and the formation of typical keratin lamellae.
A sometimes indistinct, basal membrane separates the matrix from the perimatrix or lamina propria, which is composed of granulation tissue rich in lymphocytes, histiocytes, plasma cells and neutrophylic leukocytes, with the lining mucosa which is sometimes ciliated and sometimes contains microvilli. These observations have also been confirmed in recent studies.v-'
There is a general consensus that the pathogenesis of this disorder almost always involves epithelial migration, as described both in experimental studies and in clinical trials.1, 6, 7 Eustachiantubedysfunction,H .9 due partlytoan anatomical predisposition (e.g. patients with cleft palate), creates a negative pressure on the middle ear, with retractionpockets forming in the epitympanum. An inflammatory reaction aroundthe pocket leadsto activationof the liningepithelium and keratin production. The residual keratin activates the inflammatory and local immune processes, leading to the continuous formation of new keratin, thus giving rise to a chain reaction,III especially if the cyst bursts and releases its contents into the cavity of the middle ear. Importantfindingsemergingfromrecentresearchconcern the modified local immune response, i. 
412
interleukin-I and tumor necrosis factor production by the activatedmacrophages;17 a DNA turnoverin thegerminative cell layer 3.8 times higher than in normal cutaneous tissue, nearly neoplastic," (an aspect of considerable relevance to our study); altered keratin output. 19 Numerouschemicalmediatorsof inflammationhavebeen observed in the granulationtissueof the perimatrix, particularlyarachidonicacidand itsmetabolites,211prostaglandin E2 (occurring2.6 timesmorethan inhealthytissue),prostaglandins D2 and F; thromboxaneB21evelsare also considerably higher than normal." The osteoclasts are situated between the wall of the epidermoid cyst and the underlying bone."
This brief summary of findings demonstrates that the cholesteatomawall isthesiteof intenseproliferative, inflammatory-reactive activity which triggers a local chain reaction, with a continuous growth of the epithelial cyst and erosion of the neighboring bone.
Medical therapy can prove effective if it succeeds in inhibitingthis intensepathological activity,as is the case of topical applicationsof 5-lluorouracil.
The Mechanism of Action of 5·Fluorouracil 5-tluorouracil (5-FU), a tluorinated pyrimidine, is a compound with an antimetabolitic effect which is administered usually in association with methotrexate, in the treatmentof variousmalignanttumors(of the breast,colonorrectum) and cervical lymph node metastases with capsular rupture." 5-FU inhibits methylationof the deoxy-uridylicacid into thymidylic acid, interferingwith the synthesisof DNA and, to a lesser degree, of RNA. The lack of thymine causes unbalanced growth and cell necrosis where proliferation is most intense and rapid.
5-FU was first used topically for keratosis and actinic cheilitis, and was found capable of reducing or eliminating the keratosis.t':" though dysplasia persisted. We know, however, that there is no dysplasia in the epithelial component of cholesteatoma.1
The compound has also proved effective in Queyrar's erythroplasia, Bowen's disease (intra-epithelial squamous carcinoma), condyloma acuminatum and psoriasis."
Topical 5-FU has also been applied to cholesteatoma in viewof the intensemitoticactivityof theepithelialcells in its matrix27.28.29 and it has proved able to curb the formation of keratinand reducethe excessivemucoussecretion. This behavior has also beendemonstratedinexperimentalmodels."
Materials and Methods
This paperreportson our experiencewith19patients,who are currently still being followed, having suspended treatment at least 12months ago.
We used topical applications of 5-FU for the following pathologicalconditions:
• large cavities resulting from prior ("radical") atticoantrectomy which had been exudative for years, forming keratin lamellae (7 patients); • relapsing cholesteatoma after tympanoplastic surgery (3 patients); • epitympaniccholesteatoma(8 patients, 3 of whomhave bilateral involvement): • mesotympaniccholesteatoma with no tympanic perforation underway (I patient).
The treatment was thus performed on a total of 22 ears. As it is essential,above all, to establisha completecontact betweenthe cholesteatomamatrixand the 5-FU, any epidermoid cysts extending from the aditus towards the antrum or the tubeor to the windowarea wereconsideredunsuitablefor this treatment.
Parenteral antibiotic medication was used to reduce the intensityof the exudative inflammation.
Working under considerable magnification, the cavity was cleaned to expose the wall. Small pieces of dry synthetic sponge material were positioned in the area(s) to be treated and then impregnated with 5-FU solution, leaving them in place.
This application was repeated after an interval of one month. Inthe case of a smallcavity (initialepidermoidcyst), 2-3 applicationsweresufficient;largecavitiesrequired 10to 12applications.
Contact with the skin of the canal had to be avoided to prevent ulceration.
The first signs of improvement were the disappearance of any fetor and a reduction in the exudative reaction. Once the walls had been reduced to a smooth, non-exudative, thin epithelial layer, the cyst was removed through the canal. The dry cavity remaining up against the bone was thenclosed invariousways(bymyringoplastyand myringoossiculo-plasty); the smaller cavities tended to close spontaneously.
In the 3 cases of relapsing cholesteatoma after tympanoplastyand in I endotympaniccase withnotympanic perforation, the compound was instilled transtyrnpanically (after local anesthesia), using a size 30 needle, in order to Volume 73, Number 6 achieve inactivation of the cyst wall.
Weobservednoabnormalreactionsintheareainvolvedby the applications, even when the treatment was applied transtympanically.
Results
Treatment with 5-FU stopped the formation of keratin in all patients; it was less effective, however, on the mucous hypersecretion, especiallyinthelargercavitiesderivingfrom prior attico-antrectomy (7 patients).
The procedure required the patient's close cooperation, especially in the treatment of large cavities.
After an interval of at least 12months of suspending the treatment, none of the patients showed signs of recurring keratinformation. Intheevent of thishappeninginthefuture, the 5-FU treatment could be repeated, providing that the conditions are right for it to be successful (i.e. constant contact with the region to be treated).
The results reported here are consistent with findings reported elsewhere in the literature.":" We are currently treatingother patients in the same way and our findings will be reported at a later date.
H is worth mentioning here that 5-FU could prove useful even when thedimensionsand positionof the cholesteatoma make total eradication impossible, because reducing the surroundinginflammationand keratinformationwouldcontribute to the chances of successful surgery.
Conclusions
5-FU retains its antimetabolitic effect in topical applications, as already suggested by previous findings in skin disorders(actinickeratosis,Bowen's disease,psoriasis,etc). 26 The favorable outcome of its topical use depends on:
• close and continuous contact of the 5-FU solution with the surface on which it has to take effect; • intense nuclearDNA turnoverin the cells being treated, as the compound takeseffect by reducingor cancelling such pathological activity, blocking the formation of thymine.
Said conditions occur in the cholesteatomamatrix, and 5-FU proves effective in reducing or eliminating the epidermoid cyst. Surgery should therefore be reserved for,what remains of the lesion (the cavity up against the parietal and/ or ossicularbone structures),usingmyringoand/orossiculoplasty insteadof being obliged to resort to tympanoplastyin the initial stages of this disease.
Summary
Recentstudieshavedemonstratedthatauralcholesteatoma featuresintenseDNA turnoverinthegerminativelayerofthe matrixand an immuneresponsein the wallof thecyst, which trigger a chain reaction. 5-Fluorouracil, an antimetabolitic agent that is also effective topically, was applied to the cyst wall in initial cholesteatoma, in relapsing cholesteatoma (even transtympanically) and in large exudative cavities resulting from attico-antrectomy: in all cases, it inhibited the formation of keratin and reduced the mucous hypersecretion. These results have persisted even after 12 months of suspending treatment.
